Immunosuppression in Older Renal Transplant Patients

被引:0
|
作者
Jose M. Morales
Josep M. Campistol
Amado Andrés
Juan C. Herrero
机构
[1] Hospital 12 de Octubre,Renal Transplant Unit, Nephrology Department
[2] Hospital Clinic,Renal Transplant Unit
来源
Drugs & Aging | 2000年 / 16卷
关键词
Cyclosporin; Tacrolimus; Acute Rejection; Triple Therapy; Mycophenolate Mofetil;
D O I
暂无
中图分类号
学科分类号
摘要
Renal transplantation procedures in patients older than 60 years of age have clearly improved in recent years. In the cyclosporin era, graft and patient survival are good. However, older patients exhibit a higher mortality, especially from infectious and cardiovascular causes, than young patients. In this article we review the immunosuppressive treatment in older patients, analyse what drugs can be used and finally propose several immunosuppressive combinations to treat this group of patients. Currently, new immunosuppressive drugs enable more flexible immunosuppressive protocols. Nevertheless, to avoid overimmunosuppression, elderly patients should be treated with lower doses and fewer immunosuppressive drugs.
引用
下载
收藏
页码:279 / 287
页数:8
相关论文
共 50 条
  • [21] Maintenance immunosuppression in the renal transplant recipient: An overview
    Gaston, RS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) : S25 - S35
  • [22] Anaemia is frequent in adult and paediatric renal transplant patients and is related to GFR and immunosuppression
    Al Khoury, S
    Haydar, AA
    Shah, N
    Taylor, J
    Goldsmith, DJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V271 - V271
  • [23] Immunosuppression strategies in elderly renal transplant recipients
    Camilleri, Brian
    Pararajasingam, Ravi
    Buttigieg, Jesmar
    Halawa, Ahmed
    TRANSPLANTATION REVIEWS, 2020, 34 (02)
  • [24] Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients
    Risch, L
    Herklotz, R
    Blumberg, A
    Huber, AR
    CLINICAL CHEMISTRY, 2001, 47 (11) : 2055 - 2059
  • [25] Immunosuppression in liver transplant recipients with renal impairment
    Duvoux, C.
    Pageaux, G. P.
    JOURNAL OF HEPATOLOGY, 2011, 54 (05) : 1041 - 1054
  • [26] Immunosuppression and Metabolic Syndrome in Renal Transplant Recipients
    Lo, Agnes
    METABOLIC SYNDROME AND RELATED DISORDERS, 2004, 2 (04) : 263 - 273
  • [27] CHRONIC IMMUNOSUPPRESSION OF THE RENAL-TRANSPLANT PATIENT
    HELDERMAN, JH
    VANBUREN, DH
    AMEND, WJC
    PIRSCH, JD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 4 (08): : S2 - S9
  • [28] Personalized immunosuppression in elderly renal transplant recipients
    Peeters, L. E. J.
    Andrews, L. M.
    Hesselink, D. A.
    de Winter, B. C. M.
    van Gelder, T.
    PHARMACOLOGICAL RESEARCH, 2018, 130 : 303 - 307
  • [29] A Lesson of Immunosuppression in Renal Transplant: Retreat or Hold?
    Zhang, Qian-qian
    Xie, Ya-long
    Cao, Sha
    Chen, Song
    Zhang, Wei-jie
    Chang, Sheng
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 2023, 96 (01): : 57 - 77
  • [30] The effect of rapamycin immunosuppression on native polycystic kidney volumes in renal transplant patients
    Hedgepeth, RC
    Goldfarb, DA
    Shillingford, JM
    Novick, AC
    Weimbs, T
    JOURNAL OF UROLOGY, 2006, 175 (04): : 178 - 178